- Home
- RL vs RDY Comparison
RL vs RDY Comparison
Compare RL & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RL
- RDY
- Stock Information
- Founded
- RL 1967
- RDY 1984
- Country
- RL United States
- RDY India
- Employees
- RL N/A
- RDY N/A
- Industry
- RL Apparel
- RDY Biotechnology: Pharmaceutical Preparations
- Sector
- RL Consumer Discretionary
- RDY Health Care
- Exchange
- RL Nasdaq
- RDY Nasdaq
- Market Cap
- RL 12.6B
- RDY 13.1B
- IPO Year
- RL 1997
- RDY N/A
- Fundamental
- Price
- RL $208.37
- RDY $14.17
- Analyst Decision
- RL Buy
- RDY Buy
- Analyst Count
- RL 10
- RDY 1
- Target Price
- RL $230.56
- RDY $17.00
- AVG Volume (30 Days)
- RL 663.4K
- RDY 697.0K
- Earning Date
- RL 11-07-2024
- RDY 11-05-2024
- Dividend Yield
- RL 1.58%
- RDY 6.76%
- EPS Growth
- RL 34.38
- RDY 4.63
- EPS
- RL 10.51
- RDY 0.76
- Revenue
- RL $6,740,100,000.00
- RDY $3,579,112,656.00
- Revenue This Year
- RL $5.72
- RDY $13.39
- Revenue Next Year
- RL $4.21
- RDY $8.35
- P/E Ratio
- RL $19.82
- RDY $19.00
- Revenue Growth
- RL 3.65
- RDY 12.37
- 52 Week Low
- RL $120.95
- RDY $12.90
- 52 Week High
- RL $237.16
- RDY $16.89
- Technical
- Relative Strength Index (RSI)
- RL 54.83
- RDY 30.39
- Support Level
- RL $209.02
- RDY $14.99
- Resistance Level
- RL $213.40
- RDY $15.19
- Average True Range (ATR)
- RL 6.12
- RDY 0.28
- MACD
- RL -0.16
- RDY -0.07
- Stochastic Oscillator
- RL 32.15
- RDY 11.43
About RL Ralph Lauren Corporation
Founded by designer Ralph Lauren in 1967 in New York City, Ralph Lauren Corp. designs, markets, and distributes lifestyle merchandise in North America, Europe, and Asia. Best known for its iconic polo shirts, its products also include other types of apparel, footwear, eyewear, jewelry, handbags, home goods, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, and Lauren Ralph Lauren. Distribution channels for Ralph Lauren include wholesale (department stores and specialty stores), retail (company-owned retail stores and e-commerce), and licensing.
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.